Eicarte LLC — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Eicarte LLC is a private, preclinical-stage consultancy founded in 2018 and headquartered in Cambridge, Massachusetts, with a service presence in Gettysburg, Pennsylvania. The company operates as a specialized service provider in the biotech sector, offering expert guidance on preclinical toxicology to pharmaceutical and biotech companies developing small molecule drugs. Led by founder Tracie E. Bunton, DVM, PhD, DACVP, the consultancy focuses on interpreting systems-based toxicities to de-risk development programs. Its business model is entirely service-based, positioning it as a revenue-generating entity that supports client pipelines rather than developing its own therapeutic assets.

Drug DeliverySmall Molecules

Technology Platform

Integrated expertise in pharmacology, toxicology, and veterinary pathology, specializing in the interpretation of systems-based toxicities to design, supervise, and advise on preclinical safety assessment programs.

Opportunities

Growing demand from virtual and small biotech firms lacking in-house toxicology expertise provides a steady client stream.

Increasing complexity in drug development and regulatory scrutiny creates a need for high-level, specialized consulting that large CROs may not provide in a personalized manner.

The consultancy model allows for flexible engagement on a wide variety of client molecules without the capital burden of internal R&D.

Risk Factors

Revenue is vulnerable to biotech funding cycles and client concentration, as the business relies on a limited number of projects.

The company's reputation and operations are heavily dependent on a single expert, creating key-person risk.

Competition from large, full-service CROs and other independent consultants requires constant demonstration of superior value.

Competitive Landscape

Eicarte competes in the preclinical services market, which includes large global Contract Research Organizations (CROs) like Charles River Laboratories, Labcorp, and ICON that offer comprehensive toxicology packages. Its direct competitors are other small boutique consultancies and independent expert pathologists/toxicologists. Eicarte's differentiation lies in its founder's specific board-certified pathology credentials (DACVP) and its advertised focus on interpreting complex, systems-based toxicities for strategic decision-making.

More companies in Digital Health & Biotech SaaS →More companies in United States →